Bob A. Rappaport

18.1k total citations · 2 hit papers
33 papers, 2.8k citations indexed

About

Bob A. Rappaport is a scholar working on Economics and Econometrics, Cognitive Neuroscience and Statistics, Probability and Uncertainty. According to data from OpenAlex, Bob A. Rappaport has authored 33 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 9 papers in Cognitive Neuroscience and 9 papers in Statistics, Probability and Uncertainty. Recurrent topics in Bob A. Rappaport's work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Pain Management and Placebo Effect (9 papers) and Meta-analysis and systematic reviews (8 papers). Bob A. Rappaport is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (10 papers), Pain Management and Placebo Effect (9 papers) and Meta-analysis and systematic reviews (8 papers). Bob A. Rappaport collaborates with scholars based in United States, Canada and Israel. Bob A. Rappaport's co-authors include Sharon Hertz, Robert H. Dworkin, Dennis C. Turk, John T. Farrar, Arthur F. Simone, R. Daniel Mellon, Laurie B. Burke, Penney Cowan, Sarah Peirce‐Sandner and Michael McDermott and has published in prestigious journals such as New England Journal of Medicine, Neurology and Pain.

In The Last Decade

Bob A. Rappaport

32 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2)

2009 528 citations Robert H. Dworkin, Dennis C. Turk et al. Pain profile →
Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations

2009 511 citations Robert H. Dworkin, Dennis C. Turk et al. Pain profile →

Peers

Countries citing papers authored by Bob A. Rappaport

Since Specialization

Citations

This map shows the geographic impact of Bob A. Rappaport's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob A. Rappaport with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob A. Rappaport more than expected).

Fields of papers citing papers by Bob A. Rappaport

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bob A. Rappaport. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob A. Rappaport. The network helps show where Bob A. Rappaport may publish in the future.

Co-authorship network of co-authors of Bob A. Rappaport

This figure shows the co-authorship network connecting the top 25 collaborators of Bob A. Rappaport. A scholar is included among the top collaborators of Bob A. Rappaport based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bob A. Rappaport. Bob A. Rappaport is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review 2015 ·Journal of Pain ·Shannon M. Smith, Florence Paillard, Andrew McKeown, Laurie B. Burke, Robert R. Edwards, Nathaniel P. Katz, Elektra J. Papadopoulos, Bob A. Rappaport, Ashley F. Slagle, Eric C. Strain, Ajay D. Wasan, Dennis C. Turk, Robert H. Dworkin	23
2	Deficiencies in reporting of statistical methodology in recent randomized trials of nonpharmacologic pain treatments: ACTTION systematic review 2015 ·Journal of Clinical Epidemiology ·Jordan D. Dworkin, Andrew McKeown, John T. Farrar, Ian Gilron, Matthew Hunsinger, Robert D. Kerns, Michael McDermott, Bob A. Rappaport, Dennis C. Turk, Robert H. Dworkin, Jennifer S. Gewandter	11
3	Quality of Pain Intensity Assessment Reporting: ACTTION Systematic Review and Recommendations 2015 ·Journal of Pain ·Shannon M. Smith, Matthew Hunsinger, Andrew McKeown, Melissa Parkhurst, Robert R. Allen, (unknown), Yun Lu, Hilary Wilson, Laurie B. Burke, Paul J. Desjardins, Michael McDermott, Bob A. Rappaport, Dennis C. Turk, Robert H. Dworkin	34
4	Anesthetic Neurotoxicity — Clinical Implications of Animal Models 2015 ·New England Journal of Medicine ·Bob A. Rappaport, Santhanam Suresh, Sharon Hertz, Alex S. Evers, Beverley A. Orser	223
5	Data Interpretation in Analgesic Clinical Trials With Statistically Nonsignificant Primary Analyses: An ACTTION Systematic Review 2014 ·Journal of Pain ·Jennifer S. Gewandter, Andrew McKeown, Michael McDermott, Jordan D. Dworkin, Shannon M. Smith, Robert A. Gross, Matthew Hunsinger, Allison H. Lin, Bob A. Rappaport, Andrew S.C. Rice, Michael C. Rowbotham, Mark R. Williams, Dennis C. Turk, Robert H. Dworkin	36
6	Reporting of Sample Size Calculations in Analgesic Clinical Trials: ACTTION Systematic Review 2014 ·Journal of Pain ·Andrew McKeown, Jennifer S. Gewandter, Michael McDermott, (unknown), (unknown), (unknown), John T. Farrar, Ian Gilron, Nathaniel P. Katz, Allison H. Lin, Bob A. Rappaport, Michael C. Rowbotham, Dennis C. Turk, Robert H. Dworkin, Shannon M. Smith	20
7	Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: An ACTTION study 2014 ·Pain ·John T. Farrar, Andrea B. Troxel, Kevin Haynes, Ian Gilron, Robert D. Kerns, Nathaniel P. Katz, Bob A. Rappaport, Michael C. Rowbotham, Ann Tierney, Dennis C. Turk, Robert H. Dworkin	74
8	Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations 2013 ·Pain ·Shannon M. Smith, (unknown), Nathaniel P. Katz, Michael McDermott, Laurie B. Burke, Paul Coplan, Ian Gilron, Sharon Hertz, Allison H. Lin, Bob A. Rappaport, Michael C. Rowbotham, Cristina Sampaio, Michael Sweeney, Dennis C. Turk, Robert H. Dworkin	46
9	Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations 2013 ·Pain ·Shannon M. Smith, (unknown), Anthony Pereira, Daniel R. Chang, Andrew McKeown, Kaitlin Greene, Michael C. Rowbotham, Laurie B. Burke, Paul Coplan, Ian Gilron, Sharon Hertz, Nathaniel P. Katz, Allison H. Lin, Michael McDermott, Elektra J. Papadopoulos, Bob A. Rappaport, Michael Sweeney, Dennis C. Turk, Robert H. Dworkin	24
10	Disclosure of authorship contributions in analgesic clinical trials and related publications: ACTTION systematic review and recommendations 2013 ·Pain ·Matthew Hunsinger, Shannon M. Smith, Andrew McKeown, Melissa Parkhurst, Robert A. Gross, Allison H. Lin, Michael McDermott, Bob A. Rappaport, Dennis C. Turk, Robert H. Dworkin	6
11	A Modeling and Simulation Approach to Characterize Methadone QT Prolongation Using Pooled Data From Five Clinical Trials in MMT Patients 2012 ·Clinical Pharmacology & Therapeutics ·Jeff Florian, Christine Garnett, Srikanth C. Nallani, Bob A. Rappaport, Douglas C. Throckmorton	37
12	Defining Safe Use of Anesthesia in Children 2011 ·New England Journal of Medicine ·Bob A. Rappaport, R. Daniel Mellon, Arthur F. Simone, Janet Woodcock	163
13	The Reality of Drug Shortages — The Case of the Injectable Agent Propofol 2010 ·New England Journal of Medicine ·(unknown), Bob A. Rappaport	60
14	Evidence-based clinical trial design for chronic pain pharmacotherapy: A blueprint for ACTION 2010 ·Pain ·Robert H. Dworkin, Dennis C. Turk, Nathaniel P. Katz, Michael C. Rowbotham, Sarah Peirce‐Sandner, (unknown), Chekesha S. Clingman, Benjamin C. Eloff, John T. Farrar, Cornelia Kamp, Michael McDermott, Bob A. Rappaport, Wendy R. Sanhai	53
15	Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations breakdown → 2009 ·Pain ·Robert H. Dworkin, Dennis C. Turk, Michael McDermott, Sarah Peirce‐Sandner, Laurie B. Burke, Penney Cowan, John T. Farrar, Sharon Hertz, Srinivasa N. Raja, Bob A. Rappaport, Christine Rauschkolb, Cristina Sampaio	511
16	Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2) breakdown → 2009 ·Pain ·Robert H. Dworkin, Dennis C. Turk, Dennis A. Revicki, Gale Harding, Karin S. Coyne, Sarah Peirce‐Sandner, (unknown), (unknown), Laurie B. Burke, Penney Cowan, John T. Farrar, Sharon Hertz, Mitchell B. Max, Bob A. Rappaport, Ronald Melzack	528
17	Use of Anesthetic Agents in Neonates and Young Children 2007 ·Anesthesia & Analgesia ·R. Daniel Mellon, Arthur F. Simone, Bob A. Rappaport	262
18	Multiple Sclerosis as a Cause of Atrial Fibrillation and Electrocardiographic Changes 1992 ·Archives of Neurology ·Werner Schroth, Scott Tenner, Bob A. Rappaport, (unknown)	27
19	Verification of Sleep Apnea Using a Portable Sleep Apnea Screening Device 1990 ·Southern Medical Journal ·Hélène A. Emsellem, (unknown), Bob A. Rappaport, (unknown), (unknown), (unknown)	68
20	An unusual case of proctalgia 1990 ·Annals of Emergency Medicine ·Bob A. Rappaport, Hélène A. Emsellem, (unknown), (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact